Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.2707
-0.0106 (-3.75%)
At close: Mar 27, 2026, 4:00 PM EDT
0.2707
0.00 (0.00%)
After-hours: Mar 27, 2026, 8:00 PM EDT
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $2.99 million as of March 27, 2026. Its market cap has decreased by -86.98% in one year.
Market Cap
2.99M
Enterprise Value
-4.08M
1-Year Change
-86.98%
Ranking
Category
Stock Price
$0.27
Market Cap Chart
Since November 1, 2021, Calidi Biotherapeutics's market cap has decreased from $273.84M to $2.99M, a decrease of -98.91%. That is a compound annual growth rate of -64.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 2.85M | -66.66% |
| Dec 31, 2025 | 8.56M | -61.46% |
| Dec 31, 2024 | 22.21M | -58.52% |
| Dec 29, 2023 | 53.55M | -46.69% |
| Dec 30, 2022 | 100.46M | -64.38% |
| Dec 30, 2021 | 282.04M | 2.99% |
| Nov 1, 2021 | 273.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enveric Biosciences | 2.61M |
| XORTX Therapeutics | 2.56M |
| Adial Pharmaceuticals | 2.34M |
| Oragenics | 2.30M |
| Bone Biologics | 1.99M |
| Scinai Immunotherapeutics | 1.89M |
| Iterum Therapeutics | 1.88M |
| Ensysce Biosciences | 1.87M |